09887.HK
Nanjing Leads Biolabs Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 64.00
−5.47%Margins
Gross margin
100.0%
EBITDA margin
-22.3%
EBIT margin
-28.1%
Net margin
-38.2%
FCF margin
-13.7%
-5.3%
Return on equity
-3.8%
Return on assets
-3.2%
Return on invested capital
0.10x
Asset turnover
-HKD 30.7M
Cash from operations
HKD 10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025